Carbidopa, Levodopa and Entacapone 31.25 mg/1

Carbidopa, Levodopa and Entacapone 31.25 mg/1 is a combination medication used to manage symptoms of Parkinson's disease. This oral tablet helps improve muscle control and reduce tremors, stiffness, and other motor symptoms.

Carbidopa, Levodopa and Entacapone 31.25 mg/1 is primarily used to treat Parkinson's disease. It works by increasing the levels of dopamine in the brain, which helps to alleviate symptoms such as tremors, rigidity, and difficulty moving. This medication is often prescribed when other treatments are not effective or when a combination of drugs is needed for better symptom control.

Common effects of Carbidopa, Levodopa and Entacapone 31.25 mg/1 may include nausea, dizziness, and headache. Some users might experience involuntary movements, changes in mood, or fatigue. These effects can vary and may not affect everyone who takes the medication.

Carbidopa, Levodopa and Entacapone 31.25 mg/1 should be handled with care. It is important to follow the prescribed dosage and not to stop taking the medication suddenly without consulting a healthcare provider. This medication may cause drowsiness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you.

Carbidopa, Levodopa and Entacapone 31.25 mg/1 may interact with other medications, including antidepressants, antipsychotics, and certain pain relievers. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol should be avoided as it can increase the risk of side effects.